The US has been left with a huge stockpile of hydroxychloroquine, after the World Health Organization abandoned research into the drug as a treatment for COVID-19.
Researchers from Imperial College London have begun clinical trials of a new coronavirus vaccine, backed by funding from the UK government and philanthropic donations.
NICE has recommended NHS funding for Roche’s Rozlytrek (entrectinib) as a treatment option for advanced non-small cell lung cancer with a rare mutation in final draft guidance.
AbbVie will pay Danish antibody specialist Genmab $750 million upfront for rights to a series of drugs headed by epcoritamab, a bispecific antibody in development for non-Hodgk
South Korea’s Celltrion Healthcare has begun a UK trial of its infliximab biosimilar to see if the drug can accelerate recovery from symptoms of COVID-19.
Germany’s Boehringer Ingelheim is to make a bank of its molecules available to scientists in a bid to encourage open innovation during the COVID-19 pandemic, when many scientists are workin